A20 Facilitates Oxaliplatin Sensitivity in Colorectal Cancer Through Monoubiquitylation of IKK‐β

Documenti analoghi

• Mitotic Arrest Deficient 2 Like 1 Contributes to Colorectal Cancer Cell Migration, Invasion, and Oxaliplatin Resistance Through the Wnt/β‐Catenin Pathway
  di: Xiang Ding, et al.
  Pubblicazione: (2024)
• Puerarin Enhances the Sensitivity of Colorectal Cancer to 5‐Fluorouracil and Oxaliplatin by Inhibiting the PTEN/PI3K/AKT Signaling Pathway
  di: Xiaowei Wang, et al.
  Pubblicazione: (2025)
• Influence of Citrobacter freundii on NINJ2 Expression and Oxaliplatin Resistance in Colorectal Cancer
  di: Reio Ueta, et al.
  Pubblicazione: (2025)
• Single‐Cell RNA Sequencing Reveals LEF1 as a Prognostic Biomarker for Poor Outcomes in Oxaliplatin‐Resistant Colorectal Cancer
  di: Pin Huang, et al.
  Pubblicazione: (2025)
• NEIL3 Deficiency Enhances HCC Cell Sensitivity to Oxaliplatin by Inhibiting the Fanconi Anaemia Pathway
  di: Jialiang Wang, et al.
  Pubblicazione: (2025)